1. FOLFOXIRI and bevacizumab in patients with early-onset metastatic colorectal cancer. A pooled analysis of TRIBE and TRIBE2 studies. (May 2022) Authors: Antoniotti, Carlotta; Germani, Marco M.; Rossini, Daniele; Lonardi, Sara; Pietrantonio, Filippo; Santini, Daniele; Marmorino, Federica; Allegrini, Giacomo; Daniel, Francesca; Raimondi, Alessandra; Borelli, Beatrice; Zaniboni, Alberto; Conca, Veronica; Abraham, Jim; Spetzler, David; Maiello, Evari... Journal: European journal of cancer Issue: Volume 167(2022) Page Start: 23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications. (1st September 2021) Authors: Moretto, Roberto; Elliott, Andrew; Zhang, Jian; Arai, Hiroyuki; Germani, Marco Maria; Conca, Veronica; Xiu, Joanne; Stafford, Phillip; Oberley, Matthew; Abraham, Jim; Spetzler, David; Rossini, Daniele; Antoniotti, Carlotta; Marshall, John; Shields, Anthony; Lopes, Gilberto; Lonardi, Sara; Pietran... Journal: Journal of the National Cancer Institute Issue: Volume 114:Number 2(2022) Page Start: 271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Discoidin Domain Receptor-Driven Gene Signatures as Markers of Patient Response to Anti–PD-L1 Immune Checkpoint Therapy. (3rd August 2022) Authors: You, Sungyong; Kim, Minhyung; Hoi, Xen Ping; Lee, Yu Cheng; Wang, Li; Spetzler, David; Abraham, Jim; Magee, Dan; Jain, Prerna; Galsky, Matthew D; Chan, Keith Syson; Theodorescu, Dan Journal: Journal of the National Cancer Institute Issue: Volume 114:Number 10(2022) Page Start: 1380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗